CoVid19 PILLS by Merck and Pfizer are in the midst of Stage 2 Trials! The UK has already authorized the use of Merck’s pill and both pharma’s are looking to come in the backdoor of the FDA for quick profits and ‘no liability’ arrangements… again.
Merck Pill Headline: A Merck Trial in Vietnam Showed No Deaths!
That would be the first and only trial in which 400 people – ‘volunteered’ via government request and had very mild symptoms of CoVid, were unvaccinated, and were considered ‘at risk’.
The Pill, Molnupiravir, was invented by Emory University’s biotech department with funding from NIH and the US Department of Defense. The Trial stipulates that the Drug is to be tolerable and the efficacy is measured by a negative test for CoVid19 using the PCR Test which is eliminated from use no later than December 31, 2021 – according to NIH due to its inability to differentiate between CoVid, Flu and Cold.
In the Trials, its efficacy was based on a parallel control wherein the victims were given ‘no treatment’ at all. Thus the hypothesis resulted in a conclusion that the Pill was more effective than doing ‘nothing’. It requires 10 doses per person over 5 days and costs upwards of $2100.
There have been 7 different studies according to Merck’s website. The largest involved 1850 participants, the smallest was just 96. No “results” of any of the studies have been published – all reference Trials 1 or 2. Death – in the study – was from any cause.
Merck has NOT provided any details on the participants, the outcomes, or side effects.
PFIZER CoVid PILL Headline: Pfizer ‘experimental’ Pill can cut the risk of dying or ending up in the hospital by 89%.
Pfizer CEO, Bourla, is quick to emphasize that everyone needs to continue vaccinating indefinitely and then take the PILL to protect you when you get the virus. Except that according to the “Trials” the PILL is only for ‘unvaccinated’, right CEO Bourla?
Oddly, RBC Capital Market Analyst, Brian Abrahams, told ‘investors’ that the PILL will make the markets rebound and all will return to ‘normal’… Magically! As espoused via an an investment advisor – not a ‘doctor of virology’.
Pfizer’s Trial 2/3 included a whopping 1219 unvaccinated participants. The study has not been published, is not peer reviewed, and is unavailable. YET, they have submit their request for emergency authorization via the Pharma marketing agency – the FDA.
The main media hype is that it is a ‘Pill’, something you can go home and take… However, it only works at all if you take it within 3 days of your first symptom. Meaning, people will have to try and get a prescription before they have symptoms in order to fit the 3 day window.
The insanity of these Pills and the investment advisors and doctors promoting them is that according to Trials for BOTH they only work on the unvaccinated and preclude anyone below the age of 60 while requiring a short list of comorbidities that are required and a long list of comorbidities that are NOT allowed. Symptoms must be mild.
To put that into perspective: An unvaccinated over age 60 obese diabetic person who suddenly has a cough or fever, must immediately go to a clinic, be diagnosed with CoVid via a PCR test that is no longer in existence, and then get a prescription to begin the medication all within a 3 day time span. And somehow, this is going to save the US economy and our entire population… despite the limited trials, unknown side effects, and no actual published data or peer reviewed studies of ANY of the Trials.
Yes Dear – Sign ME UP!